Cytokinetics (CYTK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 18,474 | 7,530 | 94,588 | 70,428 | 55,828 |
| Gross Profit | 18,474 | 7,530 | 94,588 | 70,428 | 55,828 |
| Operating Expenses | 554,722 | 503,735 | 418,790 | 256,741 | 149,771 |
| Operating Income | -536,248 | -496,205 | -324,202 | -186,313 | -93,943 |
| Interest Expense | 86,512 | 57,668 | 51,156 | 29,332 | 38,676 |
| Other Income | 33,234 | 27,629 | -13,597 | 331 | 5,329 |
| Pre-tax Income | -589,526 | -526,244 | -388,955 | -215,314 | -127,290 |
| Net Income Continuous | -589,526 | -526,244 | -388,955 | -215,314 | -127,290 |
| Net Income | $-589,526 | $-526,244 | $-388,955 | $-215,314 | $-127,290 |
| EPS Basic Total Ops | -5.26 | -5.45 | -4.33 | -2.80 | -1.97 |
| EPS Basic Continuous Ops | -5.26 | -5.45 | -4.33 | -2.80 | -1.97 |
| EPS Diluted Total Ops | -5.26 | -5.45 | -4.33 | -2.80 | -1.97 |
| EPS Diluted Continuous Ops | -5.26 | -5.45 | -4.33 | -2.80 | -1.97 |
| EPS Diluted Before Non-Recurring Items | -5.26 | -5.45 | -4.06 | -2.80 | -1.97 |
| EBITDA(a) | $-526,717 | $-484,313 | $-318,388 | $-184,037 | $-92,112 |